{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T17:53:59Z","timestamp":1772301239424,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1053\/j.semnuclmed.2010.11.002","type":"journal-article","created":{"date-parts":[[2011,1,26]],"date-time":"2011-01-26T04:30:02Z","timestamp":1296016202000},"page":"96-104","source":"Crossref","is-referenced-by-count":15,"title":["To Ablate or Not to Ablate: Issues and Evidence Involved in 131I Ablation of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma"],"prefix":"10.1053","volume":"41","author":[{"given":"Stanley J.","family":"Goldsmith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2010.11.002_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0001-2998(96)80020-1","article-title":"Radioiodine and thyroid disease: The beginning","volume":"26","author":"Becker","year":"1996","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1097-0142(196007\/08)13:4<745::AID-CNCR2820130416>3.0.CO;2-J","article-title":"Radioactive iodine (I-131) in the postoperative treatment of thyroid cancer","volume":"13","author":"Blahd","year":"1960","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib3","first-page":"1287","article-title":"An analysis of \u201cablation of thyroid remnants\u201d with I-131 in 511 patients from 1947-1984 J","volume":"25","author":"Bierwaltes","year":"1984","journal-title":"Nucl Med"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/thy.1997.7.265","article-title":"Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma","volume":"7","author":"Mazzaferri","year":"1997","journal-title":"Thyroidology"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s00268-002-6612-1","article-title":"Papillary thyroid carcinoma managed at the Mayo clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients","volume":"26","author":"Hay","year":"2002","journal-title":"World J Surg"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib6","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/1097-0142(19840215)53:4<982::AID-CNCR2820530427>3.0.CO;2-E","article-title":"Pulmonary metastases in differentiated thyroid carcinoma","volume":"53","author":"Massin","year":"1984","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib7","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2003-031167","article-title":"A systemic review and metaanalysis of the effectiveness of radioiodine remnant ablation for well-differentiated thyroid cancer","volume":"89","author":"Sawka","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroidology"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib9","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2434::AID-CNCR5>3.0.CO;2-M","article-title":"The national Cancer Database Report on Thyroid Carcinoma: reflections of practice patterns","volume":"83","author":"Shaha","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib10","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1210\/jc.2004-1189","article-title":"apillary thyroid microcarcinoma: outcomes and implications for treatment [Editorial]","volume":"89","author":"Pearce","year":"2004","journal-title":"J Clin Endocrinol Metabolism"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib11","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2005-2372","article-title":"Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients","volume":"91","author":"Roti","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/thy.2007.0203","article-title":"Treatment of micropapillary carcinoma of the thyroid: where do we draw the line?","volume":"17","author":"McDougall","year":"2007","journal-title":"Thyroidology"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/thy.2008.0270","article-title":"Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients","volume":"19","author":"Mercante","year":"2009","journal-title":"Thyroidology"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJM199709253371304","article-title":"Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma","volume":"337","author":"Ladenson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib15","first-page":"1482","article-title":"A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation","volume":"43","author":"Robbins","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib16","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1001\/jama.283.17.2272","article-title":"Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma","volume":"283","author":"Grigsby","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib17","series-title":"Nuclear Medicine Annual","first-page":"329","article-title":"The use of radiodine in the management of thyroid cancer","author":"Hurley","year":"1983"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib18","first-page":"1132","article-title":"Radioiodine-131 therapy for well-differentiated thyroid cancer: A quantitative radiation dosimetric approach\u2014Outcome and validation in 85 patients","volume":"33","author":"Maxon","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib19","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1210\/jc.2003-031152","article-title":"Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: A randomized clinical trial in 509 patients","volume":"89","author":"Bal","year":"2004","journal-title":"J Clin Endocrinal Metab"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib20","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.surg.2008.07.023","article-title":"Extra-thyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma","volume":"144","author":"Arora","year":"2008","journal-title":"Surgery"},{"key":"10.1053\/j.semnuclmed.2010.11.002_bib21","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1089\/thy.2009.1611","article-title":"Benefits and risks of I-131 therapy in patients with well-differentiated thyroid carcinoma","volume":"19","author":"Van Nostrand","year":"2009","journal-title":"Thyroidology"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299810001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299810001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T03:24:48Z","timestamp":1543980288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299810001467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0001299810001467"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2010.11.002","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}